Conexeu Sciences opens Vancouver R&D lab at adMare M4 centre
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform
June 25, 2026 8:30 AM EDTRENO, Nev., June 25, 2026 (GLOBE NEWSWIRE) -- Conexeu Sciences Inc. (Nasdaq: CNXU) (Conexeu or the Company), a biotechnology company advancing tissue regeneration, announced the opening of its new research and development facility at adMare BioInnovations' M4 Innovation Centre in Vancouver, Canada, a purpose-built hub for leading life sciences companies.
Conexeu commemorated the milestone with a ribbon-cutting ceremony on Tuesday,... More
